Prihlásiť sa Zaregistrujte sa zadarmo

Vlastníctvo manažmentu spoločnosti Kazia Therapeutics

Aká je hodnota metriky Vlastníctvo manažmentu spoločnosti Kazia Therapeutics?

Hodnota metriky Vlastníctvo manažmentu spoločnosti Kazia Therapeutics Limited je 20.95%

Aká je definícia metriky Vlastníctvo manažmentu?



Vlastníctvo manažmentu (Insider Ownership) je pomer akcií vlastnených akcionármi v rámci firmy (vlastniaci viac než 5% spoločnosti alebo s titulom riaditeľa či vedúceho oddelenia) a všetkých vydaných akcií.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Vlastníctvo manažmentu spoločností v sektore Health Care sektor na ASX v porovnaní so spoločnosťou Kazia Therapeutics

Čomu sa venuje spoločnosť Kazia Therapeutics?

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.

Firmy s metrikou vlastníctvo manažmentu podobnou spoločnosti Kazia Therapeutics